Study of human isoursodeoxycholic acid metabolism

Journal of Hepatology

Volumn 26, Issue 4, 1997, Pages 863-870

  Marschall, Hanns Ulrich ^a   Roeb, Elke ^a   Yildiz, Yildiz ^a   Busch, Norbert ^a   Nguyen, Huan ^a   Purucker, Edmund ^a   Thomas, Hans Günther ^a   Matern, Siegfried ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

bile acid metabolism; fast atom bombardment mass spectrometry; gas chromatography mass spectrometry; glucosidation; glucuronidation; isoursodeoxycholic acid; N acetylglucosaminidation; ursodeoxycholic acid

Indexed keywords

BILE ACID; ISOURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CELL PROTECTION; DRUG ABSORPTION; DRUG METABOLISM; DRUG SYNTHESIS; GAS CHROMATOGRAPHY; HEPATOBLASTOMA; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LIVER FUNCTION TEST; MALE; MASS SPECTROMETRY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030909046     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80254-1     Document Type: Article

References (28)

1. Leuschner U, Fischer H, Kurtz W, Güldütuna S, Hübner K, Hellstern A, Gatzen M, Leuschner M. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind study. Gastroenterology. 97:1989;1268-1274.
2. UDCA-PBC Study Group Poupon RE, Balkau B, Eschwège E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med. 324:1991;1548-1554.
3. Oka H, Toda G, Ikeda Y, Hashimoto N, Hasumura Y, Kamimura T, Ohta Y, Tsuji T, Hattori N, Namihisa T, Nishioka M, Ito K, Sasaki H, Kakumu S, Kuroki T, Fujisawa K, Nakanuma Y. A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis. Gastroenterol Jpn. 25:1991;774-780.
4. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Witt-Sullivan H, Worobetz LJ, Milner RA, Wanless IR. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 19:1994;1149-1156.
5. Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM, Lésage G, Rossi SS, Hofmann AF. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology. 106:1994;1284-1290.
6. UDCA-PBC Study Group Poupon RE, Poupon R, Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med. 330:1994;1342-1347.
7. Maeda M, Öhama H, Takeda H, Yabe M, Nambu M, Namihisa T. Identification of 3β,7β-dihydroxy-5β-cholan-24-oic acid in serum from patients treated with ursodeoxycholic acid. J Lipid Res. 25:1984;14-26.
8. Koopman BJ, Wolthers BG, Van der Molen JC, Nagel GT, Kruizinga W. Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid. Biochim Biophys Acta. 917:1987;238-246.
9. Batta AK, Arora R, Salen G, Tint GS, Eskreis D, Katz S. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment. J Lipid Res. 30:1989;1953-1962.
10. Stiehl A, Rudolph G, Raedsch R, Möller B, Hopf U, Lotterer E, Bircher J, Fölsch U, Klaus J, Endele R, Senn M. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology. 12:1990;492-497.
11. Beuers U, Fischer S, Spengler U, Paumgartner G. Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man. J Hepatol. 13:1991;97-103.
12. Fischer S, Neubrand M, Paumgartner G. Biotransformation of orally administered ursodeoxycholic acid in man as observed in gallbladder bile, serum and urine. Eur J Clin Invest. 23:1993;28-36.
13. Marschall HU, Egestad B, Matern H, Matern S, Sjövall J. N-Acetylglucosaminides: a new type of bile acid conjugate in man. J Biol Chem. 264:1989;12989-12993.
14. Matern H, Bolz R, Marschall HU, Sjövall J, Matern S. Bile acid N-acetylglucosaminides. Formation by microsonal N-acetylglucosaminyltransferases in human liver and kidney. FEBS Lett. 270:1990;11-14.
15. Marschall HU, Matern H, Wietholtz H, Egestad B, Matern S, Sjövall J. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7β-hydroxylated bile acids in man. J Clin Invest. 89:1992;1981-1987.
16. Marschall HU, Griffiths WJ, Götze U, Zhang J, Busch N, Wietholtz H, Sjövall J, Matern S. The major metabolites of ursodeoxycholic acid in human urine are conjugated with N-acetylglucosamine. Hepatology. 20:1994;845-853.
17. Neuman MG, Cameron RG, Shear NH, Bellentani S, Tiribelli C. Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced injuries in the human Hep G2 cell line. Gastroenterology. 109:1995;555-563.
18. Setchell KDR, Lawson AM, Blackstock EJ, Murphy GM. Diurnal changes in serum unconjugated bile acids in normal man. Gut. 23:1982;637-642.
19. 13C-labeled chenodeoxycholic, hyodeoxycholic, and ursodeoxycholic acids for the study of bile acid metabolism in liver disease. Clin Chim Acta. 203:1991;77-90.
20. Kimura A, Nakamura K, Makino I. Measurement of bile acid N-acetylglucosaminides in serum and urine of patients with chronic liver diseases during ursodeoxycholic acid treatment. Jpn J Gastroenterol. 92:1995;224-232.
21. Makino I, Nakagawa S. Changes in biliary lipid and biliary bile acid composition in patients after administration of ursodeoxycholic acid. J Lipid Res. 19:1978;723-728.
22. Tint GS, Salen G, Shefer S. Effects of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism. Gastroenterology. 91:1986;1007-1018.
23. Nakagawa M, Colombo C, Setchell KDR. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology. 12:1990;322-334.
24. Crosignani A, Battezzati PM, Setchell KDR, Camisasca M, Bertolini E, Roda A, M Zuin, Podda M. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study. Hepatology. 13:1991;339-344.
25. Crosignani A, Podda M, Battezzati PM, Bertolini E, Zuin M, Watson D, Setchell KDR. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology. 14:1991;1000-1007.
26. 2)ethanol. Biosynthesis of bile acids and reduction of 3-keto-5β-cholanoic acid. Eur J Biochem. 24:1972;507-519.
27. 2)ethanol. Oxidoreduction of isomeric 3-hydroxy-cholanoic acids and reduction of 3-oxo-4-cholenoic acid. Eur J Biochem. 26:1972;251-258.
28. Shefer S, Salen G, Hauser S, Dayal B, Batta AK. Metabolism of iso-bile acids in the rat. J Biol Chem. 2557:1982;1401-1406.